Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

The Medipattern Corporation V.MKI



TSXV:MKI - Post by User

Comment by goofenoffon May 28, 2012 7:48am
222 Views
Post# 19951697

RE: RE: MKI NR!

RE: RE: MKI NR!

Besides the expantion of business the NR also contains the following PP to be seriously contemplated for any investor as it dilutes the shares drastically;

The terms of the agreement (the "Transaction") include:

  1. Medipattern will issue 11,400,000 common shares to MYTRAK or its shareholders on closing. Medipattern currently has 57,404,579 million shares issued and outstanding.
  1. Medipattern will also pay $500,000 upon closing and an additional $500,000 upon satisfaction of certain milestones.
  1. MYTRAK's key personnel and related senior management will continue to spearhead the MyTrak Personal Health Solutions business unit of Medipattern.
  1. Medipattern has engaged Industrial Alliance Securities Inc. (the "Agent") to act as agent to raise, by way of private placement, at
    .25 per common share, a minimum of $3,000,000 and a maximum of $5,000,000
    with closing expected on or before June 15th, 2012 (the "Financing"). Under the terms of the Financing, the Agent will receive a cash commission representing 4% of the gross proceeds from the sale of common shares and broker warrants entitling the Agent to purchase up to that number of common shares as is equal to 8% of the aggregate number of common shares sold in the Financing, exercisable at
    .25 per share for two years from the closing date.
<< Previous
Bullboard Posts
Next >>